You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

HYPAQUE-M,75% Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Hypaque-m,75%, and when can generic versions of Hypaque-m,75% launch?

Hypaque-m,75% is a drug marketed by Ge Healthcare and is included in one NDA.

The generic ingredient in HYPAQUE-M,75% is diatrizoate meglumine; diatrizoate sodium. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the diatrizoate meglumine; diatrizoate sodium profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for HYPAQUE-M,75%?
  • What are the global sales for HYPAQUE-M,75%?
  • What is Average Wholesale Price for HYPAQUE-M,75%?
Summary for HYPAQUE-M,75%
US Patents:0
Applicants:1
NDAs:1
Clinical Trials: 4
DailyMed Link:HYPAQUE-M,75% at DailyMed
Drug patent expirations by year for HYPAQUE-M,75%
Recent Clinical Trials for HYPAQUE-M,75%

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Institute of Liver and Biliary Sciences, IndiaN/A
Spectrum Pharmaceuticals, IncPhase 2
CephalonPhase 2

See all HYPAQUE-M,75% clinical trials

US Patents and Regulatory Information for HYPAQUE-M,75%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare HYPAQUE-M,75% diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 010220-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.